EYLIO started a new chapter with a renewed energy.
Public source
Publisher name
Public post
𝗕𝗮𝗰𝗸 𝘁𝗼 𝘀𝗰𝗵𝗼𝗼𝗹, 𝗯𝗮𝗰𝗸 𝘁𝗼 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀… 𝗮𝗻𝗱 𝗯𝗮𝗰𝗸 𝘄𝗶𝘁𝗵 𝗿𝗲𝗻𝗲𝘄𝗲𝗱 𝗲𝗻𝗲𝗿𝗴𝘆! 📚✨ At EYLIO, we’re excited to start this new chapter..…
Company
EYLIO
Qualified Persons Services QP release
- Industry
- Pharmaceutical Manufacturing
- Location
- Illkirch-Graffenstaden, FR
- Company size
- 11–50 employees
About EYLIO
EYLIO is a fast-moving French pharmaceutical company that partners with biotech and medtech innovators from molecule discovery all the way to clinical success. With a highly experienced team, EYLIO offers tailored, hands-on support — from CDMO selection, quality audits, QP batch release, to clinical trial product management — and much more. Whether you're launching your first trial or scaling up, EYLIO brings agility, expertise, and a real sense of partnership to help you move forward with confidence. Curious to learn more and meet the team? Drop us a line at contact@eyliopharma.com — we’d love to hear from you!
See moreDiscover more
Similar signals
Similar public activity from other companies.
Strategy & Corporate Development
Milla Pharmaceuticals, an A.forall company
Milla Pharmaceuticals, an A.forall company announced US expansion, Licensing-In, Innovation, Commercialisation, and other initiatives.
Strategy & Corporate Development
GRM Pharma Advisory
GRM Pharma Advisory launched as a new chapter built on more than 35 years of experience in the pharmaceutical industry.
Strategy & Corporate Development
Biological E. Limited
Biological E. Limited officially launched BE Life Sciences (BELS) marking the beginning of a new chapter for the pharmaceutical business.
Strategy & Corporate Development
PharmaX Solutions
PharmaX Solutions turned 5 years old and unveiled a refreshed visual identity.
Strategy & Corporate Development
Istituto Gentili Italia